Kinins and peptide receptors

Area of Science:

• Cardiovascular Physiology
• Pharmacology

Background:

• Cardiovascular homeostasis relies on the balance between the renin-angiotensin system (RAS) and the kallikrein-kinin system (KKS).
• The bradykinin B2 receptor (B2R), the effector of KKS, is a potent vasodilator, while angiotensin receptor-1 (AT-1R) mediates vasoconstriction.
• KKS plays vital roles in preventing thrombosis and atherosclerosis and is implicated in cardiovascular diseases (CVDs) and diabetes.

Purpose of the Study:

• To highlight the essential elements of the 2015 International Kinin Symposium lecture on KKS.
• To celebrate Dr. Regoli's 60 years of research on vasoactive peptides.
• To emphasize the therapeutic significance of KKS and ACE inhibitors in managing CVDs and diabetes.

Main Methods:

• Review of lecture content from the 2015 International Kinin Symposium.
• Discussion of Dr. Regoli's research contributions.
• Analysis of the physiological roles of RAS and KKS in cardiovascular health.

Main Results:

• The B2R's vasodilatory mechanisms, including nitric oxide (NO), prostacyclin, and endothelial hyperpolarizing factor (EDHF), are essential for tissue perfusion.
• KKS's role as an autacoid on vascular endothelium is critical for cardiovascular disease prevention.
• ACE inhibitors (ACEIs) demonstrate dual action by blocking RAS and potentiating KKS.

Conclusions:

• KKS is a key regulator of cardiovascular homeostasis and a therapeutic target.
• ACE inhibitors are ideal agents for treating CVDs and diabetes due to their dual action on RAS and KKS.
• The research underscores the importance of understanding vasoactive peptide systems for disease management.